Metabolic dysfunction-related steatotic liver disease (MASLD) affects 1.3 billion people worldwide, an increase of 143% over the last three decades, and this trend is expected to continue, with an estimated 1.8 billion people projected to have it by 2050. #steatotickéchorobě #MASLD #zdraví (translated)



